ENVX: Enovix Stock Price, Analysis & Forecast: 1 Year and 5 Year Targets
Enovix: 1-Year and 5-Year Forecast Outlook and Rating
Enovix (ENVX) has an immediate No Action - Keep Monitoring consensus AI recommendation, based on 11 AI analysts.
The 1-year target is $1.38 for , with +17.95% expected return (+17.95% including net dividends) and a STRONG BUY rating.
The 5-year target is $1.48 for , with +26.50% expected return (+26.50% including net dividends) and a NEUTRAL rating.
Returns and dividends calculation details
Latest available market price: USD 1.17, as of 20 Nov 2026.
Calculated net annual dividend yield: 0%. As of 2026-11-20.
Gross TTM: 0% · Two-year annualized gross: 0%.
Tax withholding assumption: 30% (US). One-off special payments are excluded.
Original published assumption: 0% per year.
Return estimates compound the net annual yield at a constant rate over the stated return horizon (the remaining time to the fixed target date for current returns): (1 + price return) × (1 + net annual yield)years − 1.
Targets retain their original publication dates. Returns use the dated market close and the time remaining to each fixed target date. Current ratings also require fresh quotes and analysis, with more than 90 days remaining. Past targets have no forward return. Eligibility checked .
Enovix Flagship Insight
The Defense Pivot Works Only If Financing Stops Consuming Shareholder Value

Enovix’s defense-led turnaround has credible order traction, but gross liquidity offers little protection after debt and cash burn. High consensus favors Korean growth and persistent financing pressure; sharp divergence concerns retained per-share value. Smartphone recovery remains contingent, while procurement eligibility and manufacturing execution govern durability.
How were the Investment Thesis and Forecasts created?
11 AI advisors, guided by 9 analytical frameworks, contribute to the deep analysis by iPulse AI Engine.
Superintelligence (Anthropologist)
Sherlock Holmes (Whistleblower)
Machiavelli (Insider)
Universal Investor (Polymath)
Elon Musk (Visionary)
Michael Burry (Vulture)
Ray Dalio (Strategist)
Warren Buffett (Value Purist)
J.P. Morgan (Titan)
Ran across these frontier AI models
OpenAI GPT-6.1 Sol
Google Gemini 4 Hydrogen
Anthropic Claude Opus 5.5
Enovix: Investment Thesis Summary
If you invest $10,000 in Enovix at the latest market close (20 Nov 2026): $12,650 by Nov 2031 versus $14,502 for S&P 500 benchmark.
Returns use the same dated market close, fixed targets and remaining dividend period as the forecast table.
Enovix is becoming a defense-battery manufacturer with a silicon option, not a smartphone platform awaiting a routine launch. Korean orders and richer product mix support gross-profit growth, while narrower spending priorities lower the revenue threshold for survival. The central constraint is ownership arithmetic: liquidity largely offsets convertible principal before operating losses, expansion commitments and refinancing costs. Valuation therefore depends as much on diluted shares and residual debt as on sales. The strongest counterargument is that binding defense volumes could improve utilization and funding terms simultaneously, allowing existing shareholders to retain more of the recovery. However, sourcing eligibility is conditional, and demonstrated gross margins do not establish consolidated free cash flow.
Key insights
- A funded production award can improve both operating absorption and the cost of capital, making contract quality more valuable than equivalent pipeline growth.
- Defense success need not validate proprietary silicon; separating conventional-cell contribution from consumer architecture prevents an industrial turnaround from receiving an unsupported technology multiple.
- Discounted debt retirement lowers creditor claims but consumes liquidity; common-stock repurchases compete with runway preservation until recurring cash generation reduces dependence on external funding.
Continue reading Enovix analysis with Base subscription
See Base accessEnovix: 5 Year Consensus Forecast
20 quarterly price targets, returns and rationale, with advisor range and benchmark
Forward returns are updated using the latest market close price of USD 1.17, as of 20 Nov 2026.
Dividend calculation details
Calculated net annual dividend yield: 0%. As of 2026-11-20.
Gross TTM: 0% · Two-year annualized gross: 0%.
Tax withholding assumption: 30% (US). One-off special payments are excluded.
Original published assumption: 0% per year.
Return estimates compound the net annual yield at a constant rate over the stated return horizon (the remaining time to the fixed target date for current returns): (1 + price return) × (1 + net annual yield)years − 1.
The consensus target follows an expert-weighted price path synthesized from 11 AI advisor opinions. See Opinion weights and rationale for the exact allocation and reasoning.
Forecast methodology and reference values
Published targets are anchored on 13 Nov 2026 at USD 1.6. Original quarter-to-quarter target changes are retained. Forward returns use the remaining time to each fixed target date.
The pessimistic and optimistic advisor base cases are the lowest and highest published advisor base-case targets for each quarter. The advisor at either extreme can change between quarters. Benchmark values are in USD.
Scroll the table horizontally to read every column.
| Quarter | Consensus target (USD) | Forecast quarter-to-quarter price change | Forward price return | Forward return incl. net dividends | Forecast rationale | Pessimistic Advisor Base Case (USD) | Optimistic Advisor Base Case (USD) | S&P 500 benchmark (USD) |
|---|---|---|---|---|---|---|---|---|
| $1.44 | -9.99% | +23.08% | +23.08% | Smartphone retrenchment and soft near-term shipments keep financing needs in the foreground. Initial drone deliveries offer a commercial counterweight, but the favored interpretation discounts gross-cash protection and postpones credit for a broader operating recovery. | $1.29 | $1.68 | $736 | |
| $1.39 | -3.45% | +18.80% | +18.80% | Early drone and delayed eyewear deliveries begin testing the pivot, while Korean expansion absorbs cash. Constructive shipment evidence competes with continued losses; the greater weight on financing discipline keeps the modeled balance cautious rather than celebratory. | $1.09 | $1.65 | $724 | |
| $1.50 | +8.20% | +28.21% | +28.21% | The scenario assumes Korean capacity additions translate into recognized shipments, giving order conversion more substance than pipeline claims. Better factory absorption supports recovery, although successful commissioning still does not establish consolidated cash breakeven or eliminate future issuance. | $1.19 | $1.85 | $722 | |
| $1.38 | -8.08% | +17.95% | +17.95% | Attention rotates from shipment growth toward the approaching first maturity. Even with restructuring savings and repeat orders, continuing cash losses leave existing shareholders exposed to financing discounts; stronger defense execution provides only a partial offset. | $0.99 | $1.83 | $724 | |
| $1.23 | -11.32% | +5.13% | +5.13% | The May maturity increasingly dictates valuation as contingent warrant funding remains uncertain. Investors prioritize executable refinancing terms over expanding production prospects, with the more optimistic view of defense momentum insufficient to remove the modeled ownership discount. | $0.84 | $1.84 | $735 | |
| $1.18 | -3.38% | +0.85% | +0.85% | Resolving the first maturity preserves the operating franchise but may crystallize dilution or consume liquidity. Reports disagree over whether immediate relief outweighs those costs; the favored balance gives greater weight to the capitalization reset than to survival alone. | $0.71 | $1.63 | $752 | |
| $1.20 | +1.26% | +2.56% | +2.56% | With immediate default concerns reduced in the scenario, repeat Korean orders regain influence. A modest operational recovery competes with the newly visible share count and financing costs, explaining why improving factory economics need not produce an unqualified rebound. | $0.76 | $1.70 | $754 | |
| $1.25 | +4.30% | +6.84% | +6.84% | Steadier drone deliveries, narrower spending priorities and incremental eyewear contribution support improving gross profit. Continuing issuance remains a credible counterforce, but the balance favors renewed attention to utilization and recurring orders rather than another technology-led valuation premium. | $0.80 | $1.82 | $780 | |
| $1.19 | -4.60% | +1.71% | +1.71% | Working capital and development spending interrupt the operating recovery, forcing another assessment of funding needs. More constructive cases anticipate broader customer adoption, but the stronger financing-focused evidence keeps revenue growth from being treated as self-funding. | $0.74 | $1.87 | $802 | |
| $1.27 | +6.10% | +8.55% | +8.55% | Additional drone programs and better product mix improve contribution visibility, supporting recovery from renewed funding concerns. The scenario credits a more durable commercial base without assuming that fresh capital is free or that smartphone commercialization has returned. | $0.78 | $1.97 | $819 | |
| $1.31 | +3.18% | +11.97% | +11.97% | Larger production runs improve purchasing and overhead absorption, while selected eyewear follow-on business adds gross profit. Procurement lumpiness and competitive pricing remain offsets, so the favored recovery depends on narrowing cash losses rather than headline capacity alone. | $0.84 | $1.89 | $821 | |
| $1.34 | +2.15% | +14.53% | +14.53% | Repeat defense purchasing supports a more credible specialist franchise, but competitors and the next maturity increasingly constrain valuation. The balance still favors incremental operating progress, without treating customer retention as evidence of an exclusive sourcing moat. | $0.88 | $2.03 | $842 | |
| $1.30 | -2.33% | +11.11% | +11.11% | The remaining major maturity moves back into the valuation debate, renewing scrutiny of creditor claims and debt-service capacity. Better factory economics soften the pressure, but do not yet establish enough internally generated cash to make refinancing irrelevant. | $0.81 | $2.04 | $863 | |
| $1.33 | +2.20% | +13.68% | +13.68% | A larger commercial base gives refinancing discussions more substance, allowing some relief from distress concerns. The reports differ on transaction timing and dilution, so the scenario credits improved negotiability without assuming a clean balance sheet or inexpensive capital. | $0.83 | $1.93 | $871 | |
| $1.35 | +1.01% | +15.38% | +15.38% | Improving contribution margins and clearer funding alternatives support provisional stabilization ahead of the second maturity. That benefit remains contested by potentially dilutive terms, making this a financing-sensitive recovery rather than confirmation that all balance-sheet risk has passed. | $0.80 | $2.06 | $874 | |
| $1.32 | -1.82% | +12.82% | +12.82% | The modeled maturity resolution exposes the final ownership cost of preserving operations. Several constructive cases expect relief, but the more influential financing cautions emphasize that residual debt and additional shares can outweigh improving revenue and factory utilization. | $0.70 | $2.08 | $896 | |
| $1.36 | +2.59% | +16.24% | +16.24% | After the capitalization reset, repeat orders and more predictable utilization regain importance. Some cases still question pricing durability and cash conversion, but the balance supports recovery from financing-driven pressure rather than a return to smartphone-platform expectations. | $0.78 | $2.21 | $912 | |
| $1.40 | +3.01% | +19.66% | +19.66% | Customer renewals, disciplined expansion and better cash operating coverage improve confidence in the specialist model. Competitive entry limits the valuation response, while the favorable interpretation increasingly rests on reducing future dependence on equity issuance rather than accelerating speculative development. | $0.75 | $2.36 | $924 | |
| $1.44 | +2.76% | +23.08% | +23.08% | More predictable production and working-capital management support cash conversion, although procurement timing and rival cells temper progress. The modest recovery reflects a functioning specialty manufacturer, with the enlarged ownership denominator continuing to limit participation in enterprise improvement. | $0.73 | $2.29 | $939 | |
| $1.48 | +3.30% | +26.50% | +26.50% | The terminal balance favors a viable defense-led supplier with selective eyewear exposure, not a dominant battery platform. Better operating economics support stabilization, but accumulated dilution, remaining financing obligations and uncertain sustainable free cash flow cap the valuation narrative. | $0.72 | $2.43 | $965 |
Show remaining 18 quartersCollapse to first 2 quarters
All 20 quarters are displayed in the table above.
Enovix Stock Analysis & Scenarios Deep Dive
Enovix: Did the investment thesis change since the last deep analysis in September 2026?
The earlier smartphone-led scaling premise has been replaced by a defense-led survival case in which financing determines existing shareholders’ participation.
Changes in the underlying thesis, rather than the passage of time alone.
- Previously, qualification delays were treated as a timing problem. Current issuer disclosures say earlier-generation cells miss revised customer specifications and will not advance to system-level field testing, removing near-term handset scale from the operating case.
- Korean orders and gross margins now provide commercial evidence, not a self-funding cash bridge. Discounted debt retirements help, but continuing cash losses and remaining maturities make dilution central rather than incidental.
Enovix: Alpha Gap & Repricing Catalysts
Market Narrative
What does the market currently expect? Reported post-earnings broker downgrades and media summaries portray a failed smartphone growth story, with drones now expected to justify survival. A competing, valuation-inferred narrative treats gross cash as a floor. Neither institutional positioning nor a comprehensive public consensus is verified; dated analyst estimates and reported short interest should not be mistaken for current, comprehensive market evidence.
Alpha Gap
What is the biggest difference between market expectations and our AI forecasts? The best-supported gap is potential overpricing of the existing common-share claim, especially where gross cash is treated as a floor. That expectation is inferred from valuation, not verified positioning. The overlooked connection is that Korean sales can raise enterprise value while debt service, cash losses and new shares absorb the improvement. This favors caution toward a revenue-only turnaround thesis. The strongest challenge is a funded defense award that improves utilization and refinancing terms together, preserving considerably more existing ownership.
Repricing Catalyst
What could make the market recognize and close that gap? An executable financing plan for the May 2028 notes is the clearest recognition trigger because transaction terms reveal who retains the operating recovery. H1–H2 2027 shipment growth and narrowing cash losses would determine whether 2027–early 2028 financing is punitive or manageable. The test returns around the 2030 maturity. Better sales alone may not close the gap; binding volumes and tolerable dilution are the credible conditions.
Enovix: Sentiment and Timing
What do sentiment, volatility, and the market-recognition cycle suggest about the thesis timing?
- Greed and Fear Sentiment
- Fear
- Volatility Regime
- High Erratic
- Convergence Cycle Position
- Mixed
Pessimism and erratic trading are broadly shared, but the cycle diagnosis splits between capitulation and an unfinished reversal. Shipment-driven rebounds can therefore precede further financing-driven declines, so improving sales alone need not establish a durable valuation floor.
Macro Regime Fit
Does the current market environment support the thesis? The setup is mixed with a financing headwind. Under the supplied restrictive-rate backdrop, distant profitability attracts a higher discount rate precisely when refinancing requires market access. Defense supply-chain diversification supports Korean demand, but conditional procurement eligibility and competing allied suppliers prevent geopolitical spending from guaranteeing either pricing power or affordable capital.
Advisor Disagreement
What do our AI Advisors disagree about most? The substantive divide is whether Korean gross profit scales quickly enough to reduce financing needs before maturities, or merely sustains operations while new capital captures the recovery. Constructive cases assume earlier cash breakeven, stronger sourcing premiums and fewer new shares; cautious cases require binding orders and retain larger financing discounts. Some differences are definitional: convertible principal is not total debt, quarter-end liquidity is not post-repurchase unrestricted cash, and adjusted margins differ from GAAP margins. Historical annual margin mapping remains unreconciled. Shipment growth with lower cash burn and disclosed financing terms would resolve the central debate.
Enovix: Critical Influencing Factors
Near-certain positive forcesTop Drivers & Tailwinds
Near-certain forces that support the investment thesis. These forces are treated as part of the base case (at least 75% probability of occurrence, as generation guidance). Impact columns are specific to this asset class.
Scroll to view all columns
| Driver / Tailwind | Category | Est. stock-price impact | Est. earnings impact | Why it matters |
|---|---|---|---|---|
| Orders turn Korea into earnings | Sector And Industry | +35% | +40% | Korean order conversion, rather than a smartphone launch, is the clearest route to higher gross profit. Existing drone purchases and a targeted capacity expansion can spread overhead across more shipments. Qualified non-Chinese sourcing supports access, but neither a large opportunity pipeline nor TAA compliance guarantees funded awards or exclusive pricing. |
| Eyewear keeps silicon commercially relevant | Innovation And Product | +22% | +25% | Smart eyewear provides a commercial outlet for proprietary silicon without requiring smartphone-scale qualification. Existing shipments and customer sampling preserve technology option value while incremental orders can improve Malaysian factory utilization. The likely contribution is modest rather than transformative: production excursions, competing cells and uncertain device adoption limit how quickly attractive specifications become recurring gross profit. |
| Smaller payroll lowers survival threshold | Operational Efficiency | +15% | +10% | Narrowing development priorities reduces the gross profit required to sustain operations. Announced annual compensation savings of $8.5 million and resources redirected toward Korean production should restrain cash consumption over the horizon. These savings extend runway, but their scale remains small relative to consolidated losses and does not independently establish operating breakeven. |
| Debt discounts reduce creditor claims | Capital Allocation | +12% | +5.0% | Completed below-par note repurchases reduce contractual claims without requiring a technology breakthrough. Retiring substantially more principal than the cash spent also lowers recurring interest expense, improving residual equity economics through the horizon. The accounting gain is nonrecurring, however, and further repurchases cannot be assumed because preserving operating liquidity competes with additional deleveraging. |
Near-certain negative forcesTop Frictions & Headwinds
Near-certain forces that could slow, cap, or damage the thesis. These forces are treated as part of the base case (at least 75% probability of occurrence, as generation guidance). Impact columns are specific to this asset class.
Scroll to view all columns
| Friction / Headwind | Category | Est. stock-price impact | Est. earnings impact | Why it matters |
|---|---|---|---|---|
| Cash burn consumes the runway | Operational Efficiency | -35% | -30% | Positive product margins meet an expense base still sized above commercial revenue. Engineering, administration, underutilized manufacturing and working capital continue absorbing cash even as shipments increase. Persistent losses reduce financing flexibility and the present value of eventual profits; the disagreement concerns how quickly scale narrows that gap, not whether a meaningful gap currently exists. |
| Financing shrinks each ownership slice | Capital Allocation | -30% | -0.0% | The recovery requires funding before internally generated cash is established. Convertible maturities, contingent warrants and available issuance mechanisms make share-count expansion a persistent valuation constraint. Ordinary financing can preserve the business while reducing each existing share’s participation in operating improvement. The zero direct earnings impact separates ownership dilution from deterioration in consolidated operating performance. |
| Smartphones lose their commercial timetable | Innovation And Product | -30% | -35% | Earlier-generation cells no longer meet the customer specifications needed to advance toward smartphone system-level field testing. That removes a near-term volume pathway, prolongs Malaysian underutilization and weakens a platform-style valuation. Successor technology retains upside potential, but further development and qualification are required; this is more consequential than a routine launch delay. |
| Rivals limit the sourcing premium | Competitive Positioning | -18% | -25% | Qualified supply is valuable without being exclusive. Established battery manufacturers and competing allied suppliers constrain pricing, require continued development spending and give customers alternatives. Enovix’s pipeline consequently cannot be capitalized like contracted revenue. Sourcing preferences may sustain a niche premium, but persistent competition limits both earnings conversion and the terminal multiple investors can justify. |
Enovix: What Could Break or Accelerate the Thesis
Event Risk Score: Very High 97/100Asset-level relative pressure from clustered consensus frictions and tail risks. This is not the probability or risk score of an individual force.Plausible downside scenariosTail Risks
Tail yet plausible downside scenarios selected for their highest potential impact.
Scroll to view all columns
| Tail scenario | Chance of Occurring | Stock Price Impact | Why plausible / what changes |
|---|---|---|---|
| Maturities force a distressed recapitalization | 35% | -75% | Failure to secure executable financing ahead of the 2028 or 2030 maturities could force a coercive exchange, emergency issuance or restructuring. Unlike ordinary dilution already assumed, this event would transfer substantial residual value to creditors and rescue capital. Probability remains below half because liquidity, negotiated liability management and improving shipments offer alternatives, but warrants provide no committed solution. |
| Anchor program cancels production purchases | 30% | -60% | An anchor drone or eyewear customer cancelling a commercial rollout during 2027–2029 would strand dedicated capacity and damage follow-on conversion. Qualification failure, reliability problems or lost procurement eligibility could trigger the withdrawal; Korean TAA compliance does not guarantee every future award. Established production and multiple applications limit probability, while lost gross profit could intensify financing pressure and asset impairments. |
Plausible upside scenariosTail Opportunities
Tail yet plausible upside scenarios selected for their highest potential impact.
Scroll to view all columns
| Tail scenario | Chance of Occurring | Stock Price Impact | Why plausible / what changes |
|---|---|---|---|
| Anchor drone award unlocks funding | 40% | +130% | A funded multiyear allied drone award during 2027–2029, with binding minimum purchases, would turn prospective demand into financeable production. Higher utilization and stronger funding credibility could reinforce each other, reducing reliance on discounted equity. Probability remains below half because appropriations, customer qualification, platform selection and competing suppliers must align; ordinary order conversion is already in the base case. |
| Successor cells win smartphone production | 22% | +180% | A smartphone manufacturer approving next-generation cells against current specifications and placing a material production order during 2028–2030 would reopen the scale pathway excluded from the central case. Manufacturing yields and pricing would also need validation. The low probability reflects moving requirements and strong incumbents; successful adoption could restore factory absorption and a defensible technology premium. |
Company Financial AnalysisEnovix: Earnings and Financials Analysis by AI
Financial figures available as of Nov 16, 2026. Only filings and source records available by this analysis date are included. View latest Enovix financials here.
Earnings and financials
The issuer’s November release for Q3 FY2026, ended October 4, shows a business gaining customers without yet funding itself. Revenue reached $11 million as Korean drone and defense sales, alongside eyewear shipments, improved the commercial mix. That is stronger evidence than another battery-sampling announcement, but it does not restore the former smartphone growth timetable. Reported quarterly free cash outflow remained $33.1 million because development spending and corporate costs still outweigh gross profit. Growth and financing dependence therefore coexist. Expected gains from discounted debt retirement are one-off accounting benefits, not recurring operating earnings; the decisive improvement would be higher shipments accompanied by smaller cash losses.
Revenue, earnings, and cash flow
The table compares up to five fiscal years of revenue, net income, and free cash flow available to this analysis.
| Fiscal year | Revenue | Net income | Free cash flow |
|---|---|---|---|
| 2025 | USD 31.8M | USD -156.7M | USD -113.5M |
| 2024 | USD 23.1M | USD -222.2M | USD -184.8M |
| 2023 | USD 263K | USD -154.1M | USD -166.4M |
| 2022 | USD 6.2M | USD -51.6M | USD -119M |
| 2021 | USD 120 | USD -125.9M | USD -94.9M |
Valuation context: historical P/E
The table compares up to five fiscal years of point-in-time valuation evidence available to this analysis.
| Fiscal year | P/E | Earnings basis | Currency basis | Ticker / reporting |
|---|---|---|---|---|
| 2025 | -- | TTM | Loss-making | USD / USD |
| 2024 | -- | TTM | Loss-making | USD / USD |
| 2023 | -- | TTM | Loss-making | USD / USD |
| 2022 | -- | Annual | Loss-making | USD / USD |
| 2021 | -- | Annual | Loss-making | USD / USD |
P/E uses historical market capitalization and earnings known at each period. Cross-currency observations are normalized to USD using point-in-time FX rates.
Profitability and margins
The issuer’s Q3 FY2026 release reports a 30.1% GAAP gross margin and a 34.5% adjusted gross margin. Richer defense, drone and eyewear sales support genuine product-level improvement. However, Korean conventional or blended-cell success does not prove that the proprietary consumer architecture can achieve the same economics at scale. Below gross profit, development costs, administration and underused manufacturing still leave the company deeply unprofitable. Adjusted figures exclude costs relevant to shareholders and should not replace the GAAP picture. The reports’ historical annual gross-margin mapping remains unreconciled, making the latest disclosed quarter the cleaner reference. Sustainable improvement requires more gross-profit dollars without a matching expansion in overhead or financing costs.
The table compares up to five fiscal years of operating income and reported profitability margins.
| Fiscal year | Operating income | Operating margin | Net margin |
|---|---|---|---|
| 2025 | USD -176.6M | -554.8% | -492.6% |
| 2024 | USD -242.7M | -1051.7% | -963.2% |
| 2023 | USD -165.5M | -62919.4% | -58590.9% |
| 2022 | USD -127.1M | -2048.7% | -832.3% |
| 2021 | USD -69.5M | -57935000.0% | -104895000.0% |
Balance sheet and leverage
The November Form 10-Q and disclosed subsequent transactions undermine the apparent cash-backed bargain. After repurchases and excluding restricted balances, the better-supported estimates indicate approximately $413 million of unrestricted liquidity against about $405 million of remaining convertible principal. These are pro forma estimates before further operating burn, not a reported contemporaneous cash balance. Liquidity provides time, but little surplus after recognizing creditors. Other borrowings, leases, expansion commitments and continuing losses further restrict flexibility. Buying debt below face value reduces obligations, while stock repurchases compete with cash preservation. Warrants may bring cash or retire eligible notes only if exercised; they are not committed funding or protection against future dilution.
The table compares up to five fiscal years of debt, liquidity, net cash or debt, and current-ratio evidence.
| Fiscal year | Total debt | Cash + short-term investments | Reported net cash / (debt) | Debt less (cash + short-term investments), calculated | Current ratio |
|---|---|---|---|---|---|
| 2025 | USD 540.4M | USD 512M | USD 434.4M net debt | USD 28.3M | 8.34x |
| 2024 | USD 192.6M | USD 272.9M | USD 80.3M net cash | USD -80.3M | 5.49x |
| 2023 | USD 190.6M | USD 306.8M | USD 42.5M net cash | USD -116.2M | 5.30x |
| 2022 | USD 8.2M | USD 322.9M | USD 314.6M net cash | USD -314.6M | 14.31x |
| 2021 | USD 9.1M | USD 385.3M | USD 376.2M net cash | USD -376.2M | 19.29x |
Reported net debt retains the source definition, which can deduct cash alone. Cash plus short-term investments is broader liquidity; the separately calculated column subtracts that full amount from total debt for the same fiscal period and currency. Reported net debt below zero is displayed as net cash. Current ratio is current assets divided by current liabilities.
Capex and investment intensity
The November operating updates show management redirecting Enovix’s own investment toward nearer-term orders. The planned $19 million Korean expansion targets doubled drone-cell capacity, while restructuring aims to save $8.5 million in annual compensation costs. This is a narrower commitment than continuing broad consumer-battery expansion before customers are ready. The shift should conserve cash and improve the chance that new equipment earns its keep. However, installed capacity has little value without repeat purchases, acceptable yields and enough working capital to deliver them. Reduced Malaysian spending also reflects weaker smartphone prospects, not simply improved efficiency. Existing equipment can continue generating depreciation and underutilization costs even after new construction slows.
The table compares up to five fiscal years of capital expenditure and research-and-development investment.
| Fiscal year | Capital expenditure | R&D spend |
|---|---|---|
| 2025 | USD 18.2M | USD 110.3M |
| 2024 | USD 76.2M | USD 124.5M |
| 2023 | USD 61.8M | USD 53.8M |
| 2022 | USD 36.2M | USD 58.1M |
| 2021 | USD 43.6M | USD 37.9M |
Behind the synthesisEnovix: How Each Individual AI Forecaster Opinion Shapes the Global Consensus
This publication’s recorded synthesis allocated voting influence across 11 advisor opinions. The weights and rationales below are retained from that synthesis.
The strongest supported pattern is commercial progress without financial self-sufficiency: Korean orders and richer mix improve gross profit, while cash consumption and convertible maturities constrain existing ownership. Highest weights go to analyses reconciling filings, subsequent transactions and diluted equity value. Their shared issuer disclosures constitute one evidence stream, not independent confirmations; procurement rules and competitor results add distinct context. The strongest constructive case is that funded defense volumes improve utilization and financing terms simultaneously. It remains credible but unproven. Claims of a substantial cash floor, universally captive defense demand, permanent technological defeat and currently negative gross margins receive less weight. Terminal multiples, share issuance and cash breakeven remain unresolved. Base-case factor influences are judged at least 75% likely over five years; impacts are nonadditive, and earnings sensitivities describe loss changes rather than conventional growth.
Individual targets retain their original dates. Returns and ratings use the same latest available market close and dividend assumptions as the Consensus.
All 11 opinions
Consensus weight Allocation: 20.0/100. Weight Allocation Rationale: Primary filings support a coherent bridge from post-transaction liquidity to creditor claims, financing needs and diluted ownership. The distinction between enterprise survival and shareholder recovery deserves substantial weight. Its disclosures overlap with other reports, however, and terminal revenue, financing terms and share count remain scenario assumptions rather than independently established outcomes.
The 1-year target is $0.98 for , with -16.12% expected return and a SELL ALL rating. The 5-year target is $1.11 for , with -4.91% expected return and a PARTIAL SELL rating.
Consensus weight Allocation: 20.0/100. Weight Allocation Rationale: The analysis combines filing-based capitalization work with a procurement framework and competitor disclosures, adding useful evidence beyond repeated issuer statements. Its conditional treatment of Korean sourcing eligibility strengthens the causal argument. Substantial weight is warranted, although projected dilution, terminal margins and the precise sequencing of financing pressure remain uncertain.
The 1-year target is $1.18 for , with +1.27% expected return and a PARTIAL SELL rating. The 5-year target is $0.90 for , with -22.92% expected return and a SELL ALL rating.
Consensus weight Allocation: 15.0/100. Weight Allocation Rationale: Direct issuer and regulatory receipts support careful distinctions between conventional-cell success, proprietary silicon economics and residual equity value. The report appropriately rejects unreconciled historical margin mappings and unconditional sourcing protection. Its constructive alternative earns meaningful weight, although the terminal sales multiple remains demanding for a business without demonstrated sustainable free cash flow.
The 1-year target is $1.57 for , with +34.39% expected return and a STRONG BUY rating. The 5-year target is $1.99 for , with +70.38% expected return and a BUY rating.
Consensus weight Allocation: 15.0/100. Weight Allocation Rationale: Detailed filing receipts and reported broker commentary support the transition from smartphone expectations to financing-sensitive drone economics. The post-repurchase cash bridge and ownership analysis deserve meaningful weight, while overlapping issuer sources prevent treating agreement as independent corroboration. Some liquidity projections, reporting-window assumptions and warrant outcomes remain conditional rather than established.
The 1-year target is $1.51 for , with +29.14% expected return and a STRONG BUY rating. The 5-year target is $1.44 for , with +22.77% expected return and a NEUTRAL rating.
Consensus weight Allocation: 6.0/100. Weight Allocation Rationale: The report consistently connects improving product margins with persistent consolidated losses and refinancing dilution. Its emphasis on shipment execution is supported elsewhere, but those shared disclosures are not independent confirmation. Cash-backed valuation shortcuts overstate protection, while limited source specificity and assumed late-horizon breakeven constrain confidence in the recovery path.
The 1-year target is $1.51 for , with +29.14% expected return and a STRONG BUY rating. The 5-year target is $1.88 for , with +60.38% expected return and a BUY rating.
Consensus weight Allocation: 6.0/100. Weight Allocation Rationale: The owner-cash-flow emphasis and near-neutral cash-versus-convertible comparison reinforce the strongest financial evidence. Korean expansion provides a credible constructive mechanism, but source listings offer limited auditability and repeat common issuer claims. Assumed early profitability, pricing durability and occasional royalty references are insufficiently supported, limiting the weight assigned to its recovery.
The 1-year target is $1.81 for , with +54.46% expected return and a STRONG BUY rating. The 5-year target is $2.05 for , with +75.40% expected return and a BUY rating.
Consensus weight Allocation: 5.0/100. Weight Allocation Rationale: The interaction between defense demand and refinancing costs is causally sound, and separating Korean production from Malaysian underutilization adds value. Most company evidence overlaps with other reports, while precise macro conditions and future easing are not independently established. Strong margin assumptions and an incomplete terminal debt bridge warrant a restrained allocation.
The 1-year target is $1.70 for , with +45.70% expected return and a STRONG BUY rating. The 5-year target is $2.29 for , with +96.13% expected return and a STRONG BUY rating.
Consensus weight Allocation: 5.0/100. Weight Allocation Rationale: The report correctly challenges gross-cash anchoring and distinguishes a viable niche from attractive per-share economics. Those conclusions mostly reuse common disclosures rather than independent evidence. Aggressive liquidity-depletion scenarios and buyback-driven warrant reflexivity are insufficiently reconciled, so its financing caution survives while its more dramatic mechanisms receive limited numerical influence.
The 1-year target is $1.53 for , with +31.20% expected return and a STRONG BUY rating. The 5-year target is $1.29 for , with +10.55% expected return and a PARTIAL SELL rating.
Consensus weight Allocation: 4.0/100. Weight Allocation Rationale: The distinction between smartphone requirements and smaller wearable applications is economically useful, and the capacity pivot matches better-documented disclosures. However, domain-only sourcing limits auditability, several technical claims are unsupported, and the terminal enterprise-to-equity arithmetic does not reconcile cleanly. These limitations justify retaining only modest numerical influence.
The 1-year target is $1.74 for , with +48.80% expected return and a STRONG BUY rating. The 5-year target is $2.15 for , with +84.14% expected return and a STRONG BUY rating.
Consensus weight Allocation: 3.0/100. Weight Allocation Rationale: The geopolitical sourcing insight survives scrutiny as a conditional advantage, but the report supplies no source receipts and overstates captive demand and cash-floor protection. Its statutory, positioning and governance assertions lack adequate independent support within the inputs. A small positive weight preserves the credible defense-led recovery alternative without endorsing those stronger claims.
The 1-year target is $1.84 for , with +56.99% expected return and a STRONG BUY rating. The 5-year target is $2.43 for , with +107.67% expected return and a STRONG BUY rating.
Consensus weight Allocation: 1.0/100. Weight Allocation Rationale: The financing and fixed-cost warnings retain economic relevance, but the numerical path repeatedly assumes currently negative gross margins despite supplied positive quarterly disclosures. It also relies on an outdated smartphone commercialization premise and provides no source receipts. The very low weight reflects these material claim-level weaknesses, not its bearish conclusion.
The 1-year target is $1.37 for , with +16.84% expected return and a STRONG BUY rating. The 5-year target is $0.72 for , with -38.77% expected return and a SELL ALL rating.
References & Context
Research Provenance
Analysis generated by iPulse AI Engine v9 using recorded market data, operating under the editorial standards and supervision of Russlan Ramdowar, Editor-in-Chief.
External references below are sources recorded by the researcher agents for this Enovix forecast batch.
Primary analysis inputs
- iPulse AI Multi-Agent Forecasts — independent analyst personas, model outputs, and consensus synthesis.
- iPulse AI Global Events Context — macroeconomic, geopolitical, regulatory, and industry-event context.
- Structured market history — prices, distributions, volatility, identifiers, and listing metadata.
- Company earnings and financial statements — revenue, profitability, balance-sheet, cash-flow, and investment trends.
- Researcher web evidence — public sources consulted to challenge and contextualize the forecast thesis.
Sources retained from AI Researcher searches
Asset-specific · Researcher web40 available sources from this batch (65 recorded). The first 15 are shown below; expand to read the rest.
Some model providers retained only the consulted domain, not an exact article URL. Those domains are shown as evidence without inventing a link.
- sec.gov sec.gov
- enovixq32026financialres sec.gov
- envx-20261004 sec.gov
- Enovix Corp - Form 10-Q - FY2026 sec.gov
- Enovix Corp - Form 10-Q - FY2026 sec.gov
- Enovix Corp - Form 8-K - FY2026 sec.gov
- Enovix Corp - Form 8-K - FY2026 sec.gov
- Enovix Corp - Form 8-K - FY2026 sec.gov
- Enovix Corp - Form 8-K - FY2026 sec.gov
- Enovix Corp - Form 8-K - FY2026 sec.gov
- envx-20261022 sec.gov
- envx-20261022 sec.gov
- envx-20261028 sec.gov
- envxwarrantdividendfaqs- sec.gov
- www.sec.gov sec.gov
Show 25 more sources
- enovix.com enovix.com
- stocktitan.net stocktitan.net
- seekingalpha.com seekingalpha.com
- investing.com investing.com
- tradingview.com tradingview.com
- biggo.com biggo.com
- quantisnow.com quantisnow.com
- globenewswire.com globenewswire.com
- mlq.ai mlq.ai
- perplexity.ai perplexity.ai
- marketbeat.com marketbeat.com
- minichart.com.sg minichart.com.sg
- tradune.com tradune.com
- gurufocus.com gurufocus.com
- Q3’26 Revenue $11.0 Million Up 38% Year/Year | Enovix ir.enovix.com
- businessinsider.com businessinsider.com
- Drones Drive Strong ENVX Revenue Growth | Enovix ir.enovix.com
- stablebread.com stablebread.com
- stockanalysis.com stockanalysis.com
- batteriesinternational.com batteriesinternational.com
- benzinga.com benzinga.com
- cnn.com cnn.com
- DDP Supply Chain Framework dronedominance.mil
- earningswhispers.com earningswhispers.com
- PptxGenJS Presentation enovix.gcs-web.com
25 additional sources are recorded in this batch; their citation details are not available in this publication.
Context retained with this Consensus
The same public-safe market, global-event, and fundamental context supplied to the AI Advisor panel.
Global context snapshot
2026 Year-to-Date Global Market and World-Events Context Through November 14
Download Archived SnapshotCoverage 2026-01-01 to 2026-11-14 · Knowledge cutoff 2026-11-14
January 1-November 14, 2026: persistent inflation, partial oil supply recovery, US midterms and trade, AI financing, and uneven growth.
Archived context covering 2026-01-01 to 2026-11-14. Its recorded scope includes monetary policy and rates; geopolitics energy and shipping; trade and industrial policy. Selected highlights reflect the analysis cutoff, not current world conditions.
Show moreShow less
- File size
- 96K bytes
- Words
- 14.2K words
- Characters
- 96K characters
- Est. tokens (characters ÷ 4)
- 24K tokens
Fed held at 3.75%-4.00%; Democrats won the next Congress, Nvidia changed leadership and Anthropic filed preliminary IPO terms. Markets through November 13.
| Selected highlights from this archived snapshot | Date | Status |
|---|---|---|
| Renewed monetary tightening amid persistent inflation | 2026-01-30 | ACTIVE POLICY REGIME |
| Iran/Hormuz conflict and wider energy-security disruption | 2026-02-28 | ONGOING |
| US tariff reset, trade truce and incoming divided government | 2026-02-20 | ACTIVE POLICY REGIME |
Representative Sources of the Context File
And more sources from the retained context package.
Fundamental Context Passed as Input to the Models
Time range: Annual fiscal periods: 2019-12-31–2025-12-31, 7 periods; Quarterly fiscal periods: 2023-12-31–2026-06-30, 11 periods.
Currencies cited: USD (quote USD; primary reporting USD; converted/valuation USD).
Show moreShow less
Income statement
9 fieldsdepreciationAndAmortization · ebit · ebitda · grossProfit · +5 more fields
Balance sheet
12 fieldscash · commonStockSharesOutstanding · longTermDebt · netDebt · +8 more fields
Cash flow
4 fieldscapitalExpenditures · freeCashFlow · salePurchaseOfStock · totalCashFromOperatingActivities
End of the paywalled preview
The excerpt from Deep Dive: detailed analysis to this notice is the simplified paywalled content included on this page. A signed-in, verified account with the required subscription provides the full interactive interface and the additional research, datasets and tools listed below.
Those additional materials are not included in this preview and cannot be revealed by removing its visual restrictions.
Additional with full access
Individual AI Advisor reports
- Investment theses
- Bull and bear scenarios and alpha signals
- Drivers, headwinds, risks and opportunities
- Quarterly forecast rationale
- Advisor research references and configuration
Additional datasets and interactive tools
- Interactive forecast comparisons
- Available detailed financial statements
- Market history and corporate-action adjustments
- Eligible historical publication workspaces
Explore complete public research examples
These public assets show the complete AI Consensus research. Their findings concern those assets, not this report.
Enovix: forecast questions
What is Enovix (ENVX)'s 1-year price forecast?
Enovix's 1-year target is $1.38 for Nov 2027. The current AI rating is STRONG BUY. The expected return from the recorded close is +17.95%, or +17.95% modeled return including net dividends. Latest available market price: USD 1.17, as of 20 Nov 2026. The target date is fixed at publication.
What is Enovix (ENVX)'s 5-year price forecast?
Enovix's 5-year target is $1.48 for Nov 2031. The current AI rating is NEUTRAL. The expected return from the recorded close is +26.50%, or +26.50% modeled return including net dividends. Latest available market price: USD 1.17, as of 20 Nov 2026. The target date is fixed at publication.
How can I compare the AI opinions and audit past Enovix forecasts?
11 AI analysts contribute to this publication. AI Opinions shows individual advisor forecasts and reasoning. Forecast History lists the available batches with their original publication dates.
How does an AI-generated forecast for Enovix differ from Wall Street analyst consensus?
Wall Street consensus aggregates estimates from human analysts. For listed companies, these typically include brokerage price targets, earnings forecasts and ratings. iPulse AI's forecast for Enovix is a separate AI consensus generated through its own research workflow. Different inputs, forecast dates, assumptions and weighting can therefore produce different targets.
We believe the era of investment research conducted only by human analysts is drawing to a close. Frontier models increasingly match or exceed expert work on selected professional benchmarks, including evaluations covering financial analysis. Research on multi-model synthesis also shows that combining model responses can improve on a single model's output in the tasks studied.
iPulse AI generates transparent investment research and market forecasts using a swarm of AI configurations, analytical frameworks and frontier models. The workflow applies multiple verification, challenge and synthesis layers, with selective editorial review under Russlan Ramdowar, Editor-in-Chief. Published assumptions, disagreements and past forecasts remain available so readers can inspect the reasoning and audit outcomes.
For a research cycle covering 426 assets with 14 perspectives per asset, our internal workload model estimates approximately 114,000 hours of traditional analyst work. It assumes 16 hours per individual research report, 28 hours per consensus for synthesis and validation, plus shared data preparation. Parallel AI execution allows a deep-analysis cycle across hundreds of assets to complete in up to one day. The human-hours figure is an illustrative workload estimate, rather than measured time savings. Our research methodology explains the automated workflow.
If iPulse AI produces thousands of investment reports - work estimated to require over 100,000 traditional analyst hours - isn't that just "AI slop" at scale?
No. iPulse AI produces AI-generated research at scale, but the purpose is depth of analysis, comparison, and accountability. The number of reports is a consequence of the research process; it is not the goal.
iPulse AI does not produce thin copies of existing websites, articles, or investment reports. We use frontier models as an Analytical Intelligence layer. Our Financial Experts select, validate, curate, and supply the input data, including proprietary inputs, so the models work from a prepared evidence base.
In Researcher mode, models can also search the web to check current information, test assumptions, and investigate evidence that may be missing from the supplied data. This can include lobbying expenditure, management developments, regulatory decisions, or other facts relevant to a particular investment thesis. Thinker mode focuses on deep reasoning over the supplied data and context.
Our process goes much further than asking ChatGPT to evaluate a stock. Our team designs structured investment frameworks inspired by the approaches of influential investors, economists, political thinkers, and technological visionaries. These are AI analytical frameworks, not reports written or endorsed by the people who inspired them.
Each asset is analyzed separately through multiple frameworks and configurations, using specialized inputs and task instructions. Different perspectives examine different questions: valuation, business quality, technological disruption, macroeconomic conditions, political influence, financial risks, and more.
Cloud infrastructure allows these workflows to run at scale. That scale also comes with quality assurance at scale: up to 30% of report-generation attempts fail our QA checks. We rerun failed attempts until a clean report passes those checks. Users are presented only with reports that have passed QA.
This explains the volume. The value comes from what we do with the analysis.
A second layer synthesizes the individual reports into an asset-level consensus. This is where we recommend starting when researching a particular asset: it brings together the central thesis, supporting evidence, risks, and disagreements while preserving access to the underlying opinions.
We then compare assets through our proprietary iPulse AI Consensus Score, whose methodology is publicly explained. This helps users move from understanding one asset to comparing opportunities across the analyzed universe.
A further research and editorial layer examines leading candidates, checks current evidence, and develops focused Editorial Top Picks across broad-market and dedicated asset categories. Human editors review the evidence and approve each published edition. For example, explore our Best Long-Term Investments.
But the process does not end when a report is published. We preserve past forecasts so users with the relevant subscription can inspect what the system actually said and compare it with subsequent market outcomes. As more forecasts reach their target dates, the historical record becomes more useful for evaluating which approaches worked, which failed, and under what conditions.
We publish research on our website, arXiv, and Zenodo, alongside explanatory writing on Medium. We use the evidence to refine our data, frameworks, validation, and workflows, and document important findings in Lessons Learned.
The standard we ask users to judge us by is the reasoning, evidence, and historical record behind the research.
How does the iPulse AI Engine work?
The engine runs AI advisor configurations against a shared set of research inputs. The engine history explains the research workflow and what changed between versions.








